蓝帆医疗：公司参股投资的同心医疗于2025年6月底完成上市前融资

Core Viewpoint - The company announced that its investment in Tongxin Medical is progressing towards an IPO, with the completion of pre-IPO financing expected by the end of June 2025 and the IPO process having resumed in July 2025 [1] Group 1 - The resumption of the IPO process is linked to the restart of the fifth set of standards on the Sci-Tech Innovation Board, which may accelerate the listing progress [1] - The listing process is subject to multiple factors, including macroeconomic conditions, regulatory policies, market environment, and the operational status of the company itself, indicating inherent uncertainties [1] - The company will continue to monitor the listing progress of Tongxin Medical, with specific updates to be based on publicly disclosed information from Tongxin Medical [1]